Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1959 1
1961 1
1962 1
1963 2
1964 1
1965 2
1968 1
1969 1
1970 1
1971 1
1975 1
1976 1
1977 5
1978 4
1979 5
1980 2
1981 9
1982 6
1983 8
1984 5
1985 8
1986 16
1987 19
1988 7
1989 18
1990 17
1991 19
1992 25
1993 21
1994 38
1995 33
1996 62
1997 84
1998 81
1999 85
2000 98
2001 110
2002 145
2003 159
2004 208
2005 254
2006 285
2007 319
2008 405
2009 560
2010 616
2011 718
2012 911
2013 990
2014 1209
2015 1411
2016 1458
2017 1565
2018 1752
2019 1996
2020 2300
2021 2636
2022 3140
2023 3011
2024 1250

Text availability

Article attribute

Article type

Publication date

Search Results

25,154 results

Results by year

Filters applied: . Clear all
Page 1
The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial.
Ma L, Hu X, Song L, Chen X, Ouyang M, Billot L, Li Q, Malavera A, Li X, Muñoz-Venturelli P, de Silva A, Thang NH, Wahab KW, Pandian JD, Wasay M, Pontes-Neto OM, Abanto C, Arauz A, Shi H, Tang G, Zhu S, She X, Liu L, Sakamoto Y, You S, Han Q, Crutzen B, Cheung E, Li Y, Wang X, Chen C, Liu F, Zhao Y, Li H, Liu Y, Jiang Y, Chen L, Wu B, Liu M, Xu J, You C, Anderson CS; INTERACT3 Investigators. Ma L, et al. Lancet. 2023 Jul 1;402(10395):27-40. doi: 10.1016/S0140-6736(23)00806-1. Epub 2023 May 25. Lancet. 2023. PMID: 37245517 Free PMC article. Clinical Trial.
Ultrasound-augmented cancer immunotherapy.
Liu B, Du F, Feng Z, Xiang X, Guo R, Ma L, Zhu B, Qiu L. Liu B, et al. Among authors: ma l. J Mater Chem B. 2024 Apr 17;12(15):3636-3658. doi: 10.1039/d3tb02705h. J Mater Chem B. 2024. PMID: 38529593 Review.
Proteomics in Cardiovascular disease.
Gong M, Zhang Y, Chen N, Ma LL, Feng XM, Yan YX. Gong M, et al. Among authors: ma ll. Clin Chim Acta. 2024 Apr 15;557:117877. doi: 10.1016/j.cca.2024.117877. Epub 2024 Mar 25. Clin Chim Acta. 2024. PMID: 38537675 Review.
Human transferrin receptor can mediate SARS-CoV-2 infection.
Liao Z, Wang C, Tang X, Yang M, Duan Z, Liu L, Lu S, Ma L, Cheng R, Wang G, Liu H, Yang S, Xu J, Tadese DA, Mwangi J, Kamau PM, Zhang Z, Yang L, Liao G, Zhao X, Peng X, Lai R. Liao Z, et al. Among authors: ma l. Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2317026121. doi: 10.1073/pnas.2317026121. Epub 2024 Feb 26. Proc Natl Acad Sci U S A. 2024. PMID: 38408250 Free PMC article.
Single-Cell Gene-Regulatory Networks of Advanced Symptomatic Atherosclerosis.
Mocci G, Sukhavasi K, Örd T, Bankier S, Singha P, Arasu UT, Agbabiaje OO, Mäkinen P, Ma L, Hodonsky CJ, Aherrahrou R, Muhl L, Liu J, Gustafsson S, Byandelger B, Wang Y, Koplev S, Lendahl U, Owens G, Leeper NJ, Pasterkamp G, Vanlandewijck M, Michoel T, Ruusalepp A, Hao K, Ylä-Herttuala S, Väli M, Järve H, Mokry M, Civelek M, Miller C, Kovacic JC, Kaikkonen MU, Betsholtz C, Björkegren JLM. Mocci G, et al. Among authors: ma l. Circ Res. 2024 Apr 19. doi: 10.1161/CIRCRESAHA.123.323184. Online ahead of print. Circ Res. 2024. PMID: 38639096
Fibroblasts facilitate lymphatic vessel formation in transplanted heart.
Gong H, Wang T, Sun X, Zhang Y, Qiu Y, Sun W, Zhang Y, Teng P, Hu Y, Hu X, Ma L, Xu Q, Zhao H. Gong H, et al. Among authors: ma l. Theranostics. 2024 Feb 24;14(5):1886-1908. doi: 10.7150/thno.92103. eCollection 2024. Theranostics. 2024. PMID: 38505621 Free PMC article.
25,154 results
You have reached the last available page of results. Please see the User Guide for more information.